Overview

A Therapeutic Equivalence Study of Ketoconazole Cream 2%

Status:
Completed
Trial end date:
2020-07-13
Target enrollment:
Participant gender:
Summary
Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis.
Phase:
Phase 3
Details
Lead Sponsor:
Douglas Pharmaceuticals America Ltd
Collaborators:
ACM Global Laboratories
Novum Pharmaceutical Research Services
Treatments:
Ketoconazole